News
17d
Stocktwits on MSNHims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s DullShares of telehealth provider Hims & Hers Health Inc. (HIMS) dropped over 3% on Thursday after Cigna Group’s (CI) Evernorth division announced that it would cap out-of-pocket costs at $200 per month ...
17d
Pharmaceutical Technology on MSNWegovy and Zepbound costs capped at $200 in new Evernorth programmeEvernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy (semaglutide) and Zepbound (tirzepatide) will not exceed $200. Wegovy has a ...
Vermont Business Magazine This week, the Hinesburg community celebrated the official grand opening of Kelley’s Field II.
The multi-year deal makes Evernorth Health Services the presenting partner of NBA Total Health, a holistic health platform for fans. Official release NEW YORK – Evernorth Health Services and ...
Officials held a ribbon-cutting on Wednesday for Kelley’s Field II, a new independent living community in Hinesburg.
Working closely with internal teams, the students gain firsthand insight into real-world applications, fostering a startup ...
Health plan sponsors are also expected to see a reduction in the net cost per prescription of GLP-1 medications to treat obesity.
Evernorth Health Services sees expanding opportunities in the $400 billion specialty pharmacy market, said Matt Perlberg, president of pharmacy and care delivery for the Cigna subsidiary.
To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap patients’ ...
In June, Evernorth made an interchangeable Humira biosimilar available, and more than 25% of eligible Accredo patients are now using the biosimilar. About Evernorth Health Services Evernorth ...
Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.
Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap patients’ copays for pricey GLP-1 weight loss medications, the health services business announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results